资讯
Miami Dolphins superfan Ian "Big E" Berger of Coconut Creek represents South Florida in USA Today Network bracket ...
We report the case of a 29-year-old man who presented with progressive weight loss, night sweats, abdominal pain and pruritus who was found to have obstructive jaundice and cholestatic pattern of ...
Objective A close relationship between gut microbiota and some chronic liver disorders has recently been described. Herein, we systematically performed a comparative analysis of the gut microbiome in ...
Objective To investigate, among children with inflammatory bowel disease (IBD) and elevated liver enzymes, what threshold of gamma-glutamyltransferase (GGT) best distinguishes those with and without ...
Immune checkpoint inhibitor cholangitis (IMC) due to its rarity poses difficulties in diagnosis and treatment. IMC includes a range of biliary tract injuries with different clinical and pathological ...
Secondary sclerosing cholangitis is a chronic cholestatic biliary disease, which unlike primary sclerosing cholangitis, is thought to develop as a consequence of known injuries. The presence of ...
Learn the key differences between primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), including causes, symptoms, diagnosis, and treatment options.
Objective Most prognostic models for primary sclerosing cholangitis (PSC) are based on patients referred to tertiary care and may not be applicable for the majority of patients with PSC. The aim of ...
Primary sclerosing cholangitis is the classic hepatobiliary manifestation of inflammatory bowel disease and is generally chronic and progressive. Patients frequently present with asymptomatic, ...
Linerixibat improved cholestatic pruritus in patients with primary biliary cholangitis, according to phase 3 trial results.
The European Commission has granted conditional approval for Ipsen's IQIRVO (elafibranor) for the treatment of primary biliary cholangitis in adults, marking the first new therapy for this ...
The Primary Sclerosing Cholangitis drugs in development market research report provides comprehensive information on the therapeutics under development for Primary Sclerosing Cholangitis, complete ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果